Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Breast cancer and survivorship

Written by | 14 May 2012

by Dr Alison Louise Jones (pictured) – The headline figures are that the majority of women survive a diagnosis of breast cancer: 78% of those women currently diagnosed… read more.

AACE endorses new lower LDL targets and ApoB testing

Written by | 2 May 2012

New guidelines on dyslipidemia and the prevention of atherogenesis give official sanction to something endocrinologists have been doing for years: lowering LDL targets.

Discovery could help to develop drugs for organ transplant and cancer patients

Written by | 23 Apr 2012

Loyola researchers are reporting surprising findings about a molecule that helps ramp up the immune system in some cases and suppress it in others.  The finding eventually could… read more.

BTS 2012 Report – Clinical controversy: Islets versus whole pancreas

Written by | 28 Mar 2012

by Maria Dalby reporting on the presentation by Peter Friend, University of Oxford.  Pancreas transplantation for the treatment of diabetes can be said to be unique amongst transplantations… read more.

Multiple sclerosis research doubles number of genes associated with the disease

Written by | 16 Mar 2012

Scientists have identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of this very debilitating neurological disease. Many of the genes –… read more.

Simultaneous treatment for diabetes and depression improves both

Written by | 16 Mar 2012

Brief adherence programmes improve diabetes test results and depression symptoms. Patients simultaneously treated for both Type 2 diabetes and depression showed improved medication compliance and significantly improved blood… read more.

Drug focus on diabetes

Written by | 16 Mar 2012

It is estimated that there are 2.9 million people in the UK diagnosed with diabetes1 and the incidence is increasing, as it is across the world, all the… read more.

Clot-busting therapy effective for patients with stroke history or diabetes

Written by | 16 Mar 2012

by Bruce Sylvester – Stroke patients with a history of stroke or diabetes who received clot-busting drugs post-stroke have achieved better outcomes than those who did not receive… read more.

ESOT 2011 Report – Twenty first century immunosuppression in renal transplantation: Is evolution the solution?

Written by | 12 Jan 2012

Nephrotoxicity as the Primary Driver of Failure – Fact or Fiction? – Dr Philip Halloran, Alberta Applied Genomics Center, Alberta, Canada.  The calcineurin inhibitors (CNIs), ciclosporin and tacrolimus,… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.